vaccin
current
licens
prevent
season
influenza
induc
antibodi
influenza
hemagglutinin
ha
neuraminidas
na
contain
vaccin
prepar
requir
least
two
week
immun
develop
protect
immun
vaccin
induc
protect
respons
quickli
enough
blunt
effect
infect
administ
exposur
develop
novel
vaccin
base
recombin
vesicular
stomat
viru
express
influenza
hemagglutinin
rvsv
ha
protect
mice
lethal
influenza
challeng
vaccin
administ
intramuscularli
least
hour
deliveri
influenza
challeng
viru
knowledg
first
vaccin
effect
protect
anim
lethal
influenza
challeng
deliv
system
rout
influenza
exposur
occur
induct
haspecif
immun
respons
vaccin
necessari
full
protect
challeng
anim
immun
empti
rvsv
vector
protect
equal
result
consist
model
vaccin
induc
immedi
antivir
cytokin
respons
follow
develop
humor
cellular
immun
respons
act
reduc
pulmonari
viral
load
acceler
recoveri
consist
model
mice
vaccin
specif
vaccin
rvsv
ha
high
level
serum
hour
challengevaccin
develop
serum
neutral
ab
influenza
two
day
prior
control
anim
detect
antiha
cell
present
peripher
blood
three
day
prior
control
mice
vaccin
infecti
microorgan
usual
administ
prophylact
protect
immun
gener
vaccin
individu
vaccine
encount
pathogen
vaccin
protect
emerg
circumst
howev
prophylact
vaccin
often
impract
ineffect
vaccin
smallpox
rabi
hepat
b
gener
protect
immun
human
even
vaccin
administ
exposur
virus
occur
mechan
postexposur
protect
defin
vaccin
innat
adapt
immun
respons
probabl
induc
vaccin
infect
viru
establish
fulmin
infect
caus
signific
patholog
current
two
licens
vaccin
prevent
season
influenza
human
administ
prophylact
convent
inactiv
vaccin
administ
inject
trival
cocktail
circul
influenza
strain
influenza
strain
influenza
b
strain
formalininactiv
lipidsplit
enrich
viral
hemagglutinin
ha
neuraminidas
na
altern
vaccin
live
coldadapt
viru
prepar
flumist
administ
intranas
flumist
also
contain
two
influenza
one
influenza
b
strain
influenza
strain
includ
vaccin
select
base
upon
recommend
world
health
organ
sampl
emerg
circul
influenza
virus
determin
like
caus
diseas
human
given
year
vaccin
prepar
induc
antiinfluenza
neutral
antibodi
vaccine
protect
assum
depend
upon
action
antibodi
type
influenza
vaccin
administ
prior
circul
influenza
viru
commun
allow
time
protect
immun
develop
individu
like
encount
influenza
viru
natur
time
season
influenza
epidem
gener
predict
exist
vaccin
protect
well
long
ident
predomin
circul
strain
predict
correctli
howev
signific
limit
exist
influenza
vaccin
requir
minimum
two
week
establish
protect
immun
vaccine
make
unsuit
use
postexposur
therapeut
addit
exist
vaccin
protect
highli
pathogen
avian
influenza
influenza
hpai
human
infect
recent
emerg
hpai
mortal
current
avian
influenza
strain
effici
transmit
human
human
high
mutat
rate
viru
increas
incid
human
infect
isol
report
human
human
transmiss
suggest
viru
eventu
acquir
abil
possibl
predict
precis
hpai
acquir
abil
transmit
human
pandem
strain
might
develop
influenza
vaccin
could
gener
protect
immun
shortest
time
possibl
immun
would
highli
desir
may
year
novel
viru
swine
flu
potenti
pandem
spread
emerg
human
popul
vaccin
develop
novel
induc
antibodi
titer
predict
protect
week
immun
vaccin
strain
grow
well
egg
therebi
limit
vaccin
product
effici
like
larg
portion
popul
vaccin
height
natur
flu
season
develop
novel
rvsvbase
vaccin
address
weak
exist
influenza
vaccin
recombin
vesicular
stomat
viru
vsv
base
vaccin
rapidli
induc
cellular
humor
respons
administ
system
mucos
protect
wide
rang
infecti
challeng
administ
prophylact
addit
recent
seri
report
demonstr
rvsv
express
ebola
viru
ebov
glycoprotein
could
protect
macaqu
lethal
ebov
challeng
administ
within
minut
ebov
challeng
challeng
vaccin
virus
deliv
rout
mechan
vsvbase
ebov
vaccin
protect
determin
inher
challeng
work
ebov
nonhuman
primat
make
mechanist
experi
difficult
complet
vaccin
challeng
virus
deliv
rout
possibl
vsvebov
vaccin
viru
compet
directli
host
cell
bind
andor
vaccin
induc
innat
adapt
respons
blunt
effect
ebov
infect
undertook
present
studi
determin
whether
recombin
vesicular
stomat
viru
express
hemagglutinin
rvsv
ha
influenza
could
protect
anim
influenza
challeng
administ
exposur
influenza
occur
report
balbc
mice
immun
intramuscularli
rvsv
ha
within
hour
high
dose
influenza
challeng
protect
mortal
mice
immun
empti
rvsv
vector
partial
equal
protect
suggest
innat
immun
respons
rvsv
contribut
protect
full
protect
recoveri
challeng
requir
develop
antigen
specif
respons
protect
like
depend
upon
combin
action
innat
cellular
humor
factor
mice
vaccin
rvsv
ha
high
level
serum
lung
within
hour
challeng
detect
antiinfluenza
antibodi
cell
respons
prior
detect
control
anim
result
demonstr
therapeut
immun
rvsv
base
vaccin
rescu
anim
death
signific
morbid
high
dose
influenza
challeng
may
repres
altern
use
current
influenza
vaccin
emerg
situat
convent
immun
practic
effect
model
make
use
well
character
viru
use
inbr
mice
host
organ
mechanist
studi
determin
precis
mechan
action
effect
postexposur
vaccin
feasibl
obtain
plasmid
could
use
recov
rvsv
express
influenza
gene
first
fifth
posit
vsv
genom
influenza
gene
sequenc
influenza
strain
apr
pcramplifi
plasmid
gener
provid
dr
peter
pales
mt
sinai
school
medicin
forward
primer
introduc
sal
site
upstream
code
sequenc
revers
primer
introduc
nhe
site
pcr
product
digest
xho
nhe
purifi
ligat
vector
digest
enzym
vsv
clone
vector
provid
dr
john
rose
yale
univers
allow
insert
foreign
gene
fifth
posit
vsv
genom
plasmid
recov
transform
e
coli
purifi
use
maxi
kit
qiagen
insert
sequenc
verifi
duke
sequenc
facil
recombin
viru
recov
ha
plasmid
describ
previous
briefli
cell
grown
confluenc
infect
multipl
infect
moi
vaccinia
viru
express
rna
polymeras
one
hour
infect
cell
transfect
plasmid
encod
full
length
vsv
genom
plu
foreign
gene
interest
along
pbluescriptn
pbsn
pbsp
pbsl
pbsg
vsv
indiana
serotyp
pbsg
requir
recoveri
recombin
includ
enhanc
effici
hour
cell
supernat
passag
onto
cell
filter
medium
contain
viru
collect
h
cytopath
effect
seen
viru
grown
individu
plaqu
use
prepar
stock
grown
cell
store
bhk
cell
infect
moi
vsv
recombin
control
viru
hr
medium
remov
cell
wash
twice
methioninefre
dulbecco
modifi
eagl
medium
dmem
methioninefre
dmem
ml
contain
methionin
ad
plate
two
addit
hour
medium
remov
cell
wash
phosphatebuff
salin
pb
lyse
deterg
solut
nonidet
deoxychol
mm
trishcl
ph
mm
edta
ice
min
collect
eppendorf
tube
protein
extract
centrifug
min
g
remov
nuclei
store
protein
extract
fraction
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
acrylamid
protein
visual
autoradiographi
eight
tenweekold
femal
balbc
mice
obtain
charl
river
laboratori
hous
least
week
experi
initi
mice
hous
microisol
cage
biosafeti
level
anim
facil
viral
stock
dilut
appropri
titer
serumfre
dmem
intramuscular
vaccin
im
mice
inject
indic
amount
viru
es
total
volum
intranas
challeng
influenza
mice
lightli
anesthet
isofluran
use
vapor
administ
indic
amount
viru
total
volum
institut
anim
care
use
committe
duke
univers
approv
anim
experi
influenza
challeng
mice
monitor
daili
weight
loss
chang
bodi
temperatur
physitemp
rodent
thermomet
physitemp
inc
clifton
nj
monoclon
antibodi
clone
yt
reactiv
mice
receiv
inject
day
day
day
challeng
deplet
cell
confirm
blood
peripher
blood
flow
cytometri
day
day
studi
obtain
peripher
blood
lymphocyt
blood
collect
serum
free
medium
dmem
contain
heparin
blood
layer
onto
ficol
gradient
spun
lymphocyt
collect
interfac
cell
wash
resuspend
dmem
contain
fc
obtain
lymphocyt
lung
mice
sacrif
via
anesthet
overdos
lung
asept
remov
lung
chop
fine
piec
digest
dmem
contain
fetal
bovin
serum
collagenas
worthington
lab
dnase
sigma
digest
cell
push
metal
siev
filter
micron
filter
layer
onto
ficol
gradient
lympholyt
cedarlan
lab
lymphocyt
collect
interfac
wash
stain
stain
perform
freshli
isol
lymphocyt
previous
describ
briefli
approxim
cell
ad
well
vbottom
plate
block
unconjug
streptavidin
molecular
probe
f
c
block
pharmingen
min
room
temperatur
rt
follow
centrifug
g
lymphocyt
label
fitcconjug
antibodi
pharmingen
allophycocyaninconjug
antibodi
pharmingen
tetram
min
rt
tetram
peconjug
major
histocompat
complex
mhc
class
k
tetram
nih
tetram
facil
contain
restrict
peptid
ha
niystvasslc
shaminocul
control
anim
use
determin
background
level
tetram
bind
background
routin
less
subtract
report
percentag
microneutr
assay
perform
describ
heatinactiv
serum
immun
control
anim
serial
dilut
incub
viru
one
hour
rt
residu
infect
detect
mdck
cell
day
cultur
period
neutral
titer
defin
highest
dilut
serum
complet
neutral
infect
tcid
influenza
viru
infect
defin
presenc
cpe
day
four
post
infect
mice
sacrif
via
anesthet
overdos
lung
remov
asept
dissect
lung
weigh
homogen
steril
buffer
buffer
per
organ
weight
homogen
titer
standard
plaqu
assay
mdck
cell
presenc
ml
tpcktrypsin
sigma
use
solid
agar
overlay
detect
infecti
influenza
viru
anoth
aliquot
titer
cell
detect
infecti
vsv
hr
influenza
hr
vsv
overlay
remov
cell
layer
stain
crystal
violet
visual
plaqu
infecti
vsv
detect
lung
mice
test
studi
statist
test
perform
use
graph
pad
prism
statist
analysi
softwar
result
consid
signific
p
reach
specif
analys
use
indic
text
figur
legend
obtain
replic
compet
rvsv
express
influenza
hemagglutinin
ha
insert
dna
encod
influenza
hemagglutinin
pathogen
mouseadapt
influenza
provid
dr
peter
pales
plasmid
vector
pvsv
provid
dr
john
rose
allow
recoveri
rvsv
express
influenza
hemagglutinin
fifth
transcrib
gene
vsv
genom
diagram
figur
express
influenza
ha
cell
infect
recombin
verifi
metabol
label
smethionin
sdspage
autoradiographi
figur
cell
infect
vsv
recombin
detect
indic
vsv
protein
well
new
protein
band
mobil
size
expect
influenza
ha
surfac
express
ha
surfac
infect
cell
confirm
immunofluoresc
stain
cell
infect
recombin
figur
foreign
protein
effici
incorpor
vsv
envelop
cytoplasm
tail
foreign
protein
must
replac
vsv
g
tail
elect
attach
vsv
tail
ha
therefor
sinc
viru
retain
vsv
g
effici
incorpor
ha
vsv
envelop
like
infect
host
cell
mediat
almost
entir
vsv
g
insert
ha
express
foreign
gene
rvsv
alway
attenu
rvsv
determin
whether
express
hemagglutinin
reduc
abil
rvsv
ha
replic
vitro
perform
onestep
growth
curv
shown
figur
recombin
viru
rvsv
ha
grew
equival
titer
parent
viru
vsv
rwt
indic
express
influenza
ha
attenu
rvsv
ha
vitro
shown
previous
rvsv
ha
express
ha
influenza
protect
mice
morbid
mortal
mice
immun
rvsv
ha
week
influenza
challeng
determin
whether
rvsv
ha
protect
mice
morbid
mortal
rvsv
ha
deliv
influenza
challeng
perform
experi
shown
figur
adult
balbc
mice
challeng
intranas
influenza
total
volum
immedi
within
minut
influenza
challeng
mice
either
intramuscularli
mockimmun
diluent
alon
vsv
immun
intramuscularli
pfu
rvsv
empti
vector
vsv
rwt
immun
intramuscularli
pfu
rvsv
ha
rvsv
ha
shown
figur
rvsv
ha
vaccin
balbc
mice
surviv
rate
surviv
mice
immun
rvsv
ha
significantli
higher
rate
surviv
mockimmun
mice
vsv
mantelcox
test
mice
immun
empti
vector
vsv
rwt
vsv
rwt
mantel
cox
test
two
five
mice
immun
empti
vector
vsv
rwt
surviv
rate
surviv
vsv
rwt
immun
anim
significantli
differ
mockimmun
mice
mantelcox
test
suggest
vsv
rwt
empti
vector
confer
partial
protect
specif
respons
ultim
requir
complet
protect
consist
idea
weight
loss
pattern
mice
vaccin
rvsv
ha
diverg
significantli
mice
vaccin
empti
vector
vsv
rwt
seventh
day
challeng
onward
rvsv
ha
immun
mice
recov
rapidli
figur
immun
vsv
rwt
day
challengeimmun
rvsv
immun
mice
transient
weight
loss
approxim
preinfect
bodi
weight
weight
loss
mice
immun
high
dose
vsv
correl
host
product
typic
resolv
day
post
immun
fluchalleng
mice
receiv
vsv
lose
weight
time
vsv
group
day
post
challeng
figur
support
idea
initi
weight
loss
due
vsv
influenza
pathogenesi
combin
weight
loss
measur
temperatur
depress
acut
phase
murin
influenza
infect
sensit
indic
patholog
decreas
magnitud
temperatur
loss
indic
better
clinic
outcom
enhanc
likelihood
surviv
consist
observ
immun
rvsv
induc
system
product
mice
immun
vsv
rwt
rvsv
ha
transient
rais
temperatur
c
first
hour
challeng
return
normal
hour
challeng
data
shown
second
day
challeng
onward
temperatur
except
mockchalleng
control
mice
began
declin
compar
magnitud
temperatur
depress
day
challeng
time
temperatur
chang
due
influenza
rather
vsv
pathogenesi
differ
temperatur
depress
mice
immun
rvsv
ha
vsv
rwt
statist
signific
figur
support
notion
mice
immun
empti
vector
vsv
rwt
control
infect
well
mice
immun
rvsv
ha
seventh
day
challeng
seventh
day
antigen
specif
respons
requir
surviv
recoveri
mice
vaccin
either
rvsv
ha
vsv
rwt
lost
significantli
less
temperatur
receiv
diluent
alon
rvsv
ha
vsv
rwt
respect
twotail
student
test
figur
consist
idea
nonspecif
antivir
respons
induc
rvsv
vaccin
protect
mice
patholog
seventh
day
challeng
confirm
result
first
studi
begin
elucid
mechan
respons
protect
elicit
vaccin
challeng
immun
second
larger
cohort
mice
per
group
shown
figur
also
includ
cohort
mice
immun
rvsv
ha
alon
challeng
influenza
allow
us
measur
immun
respons
virus
alon
seven
mice
group
follow
day
monitor
weight
loss
surviv
remaind
group
sacrif
perform
immun
respons
assay
shown
figur
rvsv
ha
vaccin
mice
surviv
rate
surviv
mice
immun
rvsv
ha
significantli
higher
rate
surviv
mockimmun
mice
vsv
mantelcox
test
mice
immun
empti
vector
vsv
rwt
vsv
rwt
mantel
cox
test
three
seven
mice
immun
empti
vector
vsv
rwt
surviv
first
experi
rate
surviv
vsv
rwt
immun
anim
significantli
differ
mockimmun
mice
mantelcox
test
weight
loss
mice
challeng
influenza
immun
rvsv
ha
similar
mice
challeng
influenza
immun
empti
vector
seventh
day
challeng
time
mice
immun
empti
vector
lost
weight
rapidli
mice
immun
rvsv
ha
recov
figur
mice
immun
rvsv
ha
challeng
influenza
open
diamond
figur
initi
weight
loss
approxim
day
observ
mice
receiv
vsv
confirm
initi
weight
loss
due
vsv
influenza
pathogenesi
reduc
patholog
acut
influenza
infect
human
laboratori
anim
produc
natur
result
viral
infect
provid
exogen
role
protect
inbr
mice
influenza
indirect
sinc
mani
mous
strain
includ
balbc
express
nonfunct
allel
interferon
respons
gene
mx
function
mx
directli
inhibit
transcript
influenza
genom
reduc
viral
titer
mxintact
mice
mxdefici
inbr
mice
moder
sever
pulmonari
immunopatholog
result
influenza
infect
promot
antibodi
classswitch
isotyp
determin
whether
rvsv
immun
induc
product
immun
mice
collect
serum
vaccine
mice
per
group
hour
challengevaccin
measur
amount
elisa
also
measur
bronchoalveolar
lavag
bal
fluid
whole
lung
homogen
hour
challengevaccin
detect
bal
lung
homogen
challengedvaccin
mice
serum
detect
hour
challeng
rvsv
vaccin
mice
data
shown
peak
hour
longer
detect
hour
challeng
shown
figur
detect
serum
mice
immun
rvsv
ha
vsv
rwt
serum
mice
challeng
influenza
immun
diluent
alon
vsv
group
figur
amount
serum
mice
immun
rvsv
ha
significantli
differ
amount
serum
mice
immun
empti
vector
vsv
rwt
student
test
result
support
idea
rvsv
vector
induc
nonspecif
antivir
respons
abl
protect
vaccine
seventh
day
challengeimmun
amount
serum
mice
immun
rvsv
ha
vector
alon
absenc
flu
challeng
rvsv
ha
group
figur
significantli
differ
induc
rvsv
ha
presenc
flu
support
idea
produc
respons
rvsv
rather
influenza
use
cohort
mice
shown
figur
perform
assay
shown
figur
begin
determin
mechan
vaccin
action
sacrif
four
mice
per
group
per
day
timepoint
shown
figur
determin
titer
influenza
vsv
applic
plaqu
assay
mdck
cell
respect
infecti
vsv
recov
lung
vsvimmun
anim
timepoint
test
day
post
challeng
demonstr
rvsv
deliv
intramuscularli
dissemin
lung
meant
vsv
vaccin
virus
probabl
interfer
directli
abil
influenza
infect
host
cell
pulmonari
influenza
titer
peak
mice
four
day
challeng
figur
viral
load
mice
immun
either
rvsv
vector
similar
viral
load
mice
receiv
vsv
first
six
day
challeng
suggest
nonspecif
immun
respons
induc
rvsv
immun
first
six
day
challeng
directli
limit
viral
replic
pulmonari
viral
load
mice
immun
rvsv
ha
vsv
rwt
significantli
differ
sixth
day
challeng
time
viral
load
rvsv
ha
immun
mice
declin
rapidli
viral
load
vsv
rwt
immun
mice
remain
significantli
higher
specif
begin
eighth
day
challeng
indic
asterisk
graph
figur
averag
pulmonari
viral
load
mice
vaccin
rvsv
ha
significantli
lower
averag
viral
load
control
mice
vaccin
empti
vector
vsv
rwt
p
via
oneway
anova
tukey
multipl
comparison
test
result
consist
idea
nonspecif
respons
provid
equal
protect
mice
immun
specif
empti
vector
sixth
day
challeng
suggest
specif
respons
requir
vaccin
efficaci
seventh
day
onward
directli
lower
pulmonari
viral
load
induct
ctl
eg
mice
vaccin
rvsv
ha
mice
intranas
infect
influenza
cell
prime
activ
mediastin
lymph
node
day
later
day
infect
antigenspecif
cell
present
lung
airway
epithelium
facilit
viral
clearanc
via
perforin
granzym
mediat
kill
infect
epitheli
cell
determin
whether
kinet
magnitud
cell
induct
differ
vaccin
nonvaccin
mice
system
use
mhc
class
tetram
recogn
restrict
epitop
ha
niystvasslc
quantit
haspecif
cell
peripher
blood
lung
vaccin
control
mice
repres
fac
plot
blood
lung
flu
challeng
mice
shown
figur
respect
mice
challeng
influenza
immun
rvsv
ha
detect
haspecif
cell
blood
three
day
earlier
day
vs
day
figur
rvsv
ha
vaccin
mice
vs
shamvaccin
vsv
rwt
vaccin
anim
measur
antiha
cell
respons
lung
observ
similar
pattern
rvsv
ha
immun
mice
significantli
greater
percentag
haspecif
cell
sham
inocul
mice
mice
vaccin
empti
vector
vsv
rwt
time
point
test
p
comparison
via
oneway
anova
tukey
multipl
comparison
test
figur
peripher
blood
induct
antiha
cell
synergist
mice
challeng
influenza
immun
rvsv
ha
cell
respons
rvsv
ha
vaccin
anim
significantli
greater
day
challeng
vaccin
onward
compar
mice
challeng
influenza
vaccin
rvsv
ha
alon
induct
antiha
cell
immedi
preced
recoveri
challeng
vaccine
test
whether
cell
necessari
vaccin
mediat
protect
use
monoclon
antibodi
reactiv
murin
deplet
cohort
vaccine
open
squar
figur
cell
prior
challengevaccin
rvsv
ha
deplet
protocol
result
complet
remov
cell
lung
spleen
peripher
blood
confirm
flow
cytometri
day
day
experi
data
shown
mice
surviv
challeng
weight
loss
deplet
anim
vaccin
rvsv
ha
significantli
differ
weight
loss
anim
vaccin
rvsv
ha
demonstr
cell
necessari
vaccin
mediat
protect
challeng
vaccin
model
although
remain
possibl
cell
could
enhanc
protect
heterolog
challeng
neutral
antibodi
influenza
prevent
attach
viral
ha
host
cell
induct
neutral
antibodi
major
correl
protect
human
influenza
infect
determin
whether
immun
rvsv
ha
gener
antiinfluenza
neutral
antibodi
vaccin
mice
collect
serum
rvsv
ha
vaccin
control
anim
timecours
detect
neutral
antibodi
challeng
viru
via
microneutr
assay
collect
serum
anim
per
group
day
challengevaccin
shown
figur
mice
challeng
influenza
vaccin
rvsv
ha
open
triangl
develop
antiinfluenza
neutral
antibodi
sixth
day
challengeimmun
mice
vaccin
rvsv
ha
absenc
flu
challeng
figur
open
diamond
also
develop
neutral
antibodi
six
day
immun
demonstr
coinfect
flu
posit
neg
affect
speed
serum
neutral
antibodi
induc
rvsv
ha
shamimmun
vsv
empti
vector
immun
mice
detect
serum
neutral
antibodi
day
respect
challeng
result
consist
declin
viral
titer
begin
day
mice
immun
rvsv
ha
suggest
induct
neutral
antibodi
may
contribut
protect
surviv
anim
neutral
titer
increas
recoveri
phase
infect
averag
titer
three
month
challeng
data
shown
result
consist
find
viral
load
reduc
rvsv
ha
vaccin
versu
control
mice
suggest
sinc
rvsv
ha
vaccin
anim
develop
neutral
antibodi
quickli
mock
empti
vector
immun
mice
like
induct
serum
neutral
ab
contribut
protect
induc
rvsv
ha
vaccin
determin
long
challeng
could
delay
rvsv
ha
immun
retain
protect
perform
experi
shown
figur
first
experi
balb
c
mice
mice
per
group
challeng
influenza
total
volum
mice
immun
immedi
either
rvsv
ha
vsv
rwt
per
group
figur
includ
addit
group
per
group
mice
immun
rvsv
ha
either
hour
challeng
mice
immun
rvsv
ha
hour
challeng
surviv
although
weight
loss
mice
immun
hour
sever
prolong
mice
receiv
vaccin
earlier
timepoint
figur
demonstr
rvsv
ha
vaccin
could
delay
hour
challeng
retain
efficaci
undertook
studi
determin
whether
immun
rvsv
ha
could
protect
mice
lethal
influenza
challeng
vaccin
viru
deliv
system
lethal
intranas
influenza
challeng
demonstr
mice
immun
rvsv
ha
specif
vector
mice
receiv
control
empti
vector
vsv
rwt
protect
mortal
administr
rvsv
ha
vector
could
delay
hour
challeng
full
retent
protect
show
postexposur
vaccin
influenza
feasibl
potenti
translat
use
emerg
situat
main
question
aris
result
mechan
vaccin
induc
protect
mice
immun
empti
vector
surviv
challeng
suggest
protect
partial
mediat
nonspecif
factor
howev
rate
surviv
significantli
higher
mice
vaccin
specif
vector
rvsv
ha
surviv
show
specif
respons
requir
complet
optim
protect
mind
sever
mechan
vaccin
action
consid
either
alon
combin
first
rvsv
vaccin
viru
could
directli
interf
abil
influenza
infect
host
cell
data
support
possibl
two
reason
first
rvsv
ha
vsv
rwt
would
expect
compet
equal
well
influenza
host
cell
bind
sinc
vsv
virus
infect
via
vsv
g
attach
protein
mice
immun
vsv
rwt
significantli
lower
rate
surviv
rvsv
ha
immun
mice
demonstr
mechan
protect
induc
equal
two
rvsv
second
influenza
challeng
viru
deliv
intranas
rvsv
virus
deliv
intramuscularli
distal
site
rear
quadricep
titer
infecti
viru
lung
homogen
coinfect
vaccin
mice
confirm
infecti
vsv
present
lung
mice
challeng
influenza
immun
either
rvsv
ha
vsv
rwt
show
vsv
dissemin
lung
vaccin
mice
sinc
influenza
viru
restrict
lung
model
therefor
like
vsv
vaccin
virus
interf
directli
abil
influenza
infect
host
cell
consist
result
viral
load
control
rvsv
vaccin
mice
differ
substanti
earliest
timepoint
examin
day
challeng
suggest
influenza
viru
abl
replic
equal
well
vaccin
control
mice
adapt
respons
mount
ad
evid
direct
viral
interfer
import
mechan
protect
model
second
possibl
mechan
vaccin
action
rvsv
vaccin
could
induc
nonspecif
innat
antivir
respons
promot
induct
adapt
respons
andor
inhibit
abil
influenza
replic
andor
caus
patholog
nonspecif
innat
immun
respons
theoret
would
induc
equal
rvsv
ha
specif
vector
vsv
rwt
empti
vector
induct
typei
ifn
part
earliest
innat
host
respons
viral
infect
balbc
mice
use
studi
natur
defici
ifninduc
gene
mx
inhibit
primari
transcript
influenza
viru
genom
role
model
like
indirect
rather
direct
consist
idea
detect
lung
vaccin
challeng
mice
viral
load
significantli
lower
rvsv
versu
control
mice
time
ifn
detect
result
support
idea
induc
vsv
inhibit
influenza
viru
replic
directli
rather
system
enhanc
develop
adapt
immun
respons
andor
moder
immunopatholog
induc
influenza
infect
support
idea
report
provis
exogen
protect
inbr
mxdefici
mice
influenza
infect
even
deliv
parenter
mice
unabl
respond
significantli
suscept
influenza
infect
wild
type
control
mice
mice
control
influenza
viru
replic
well
wild
type
mice
uncontrol
pulmonari
immunopatholog
reduc
antiinfluenza
humor
respons
lead
higher
rate
mortal
rel
statintact
anim
final
report
induc
rvsv
infect
significantli
augment
develop
antivir
neutral
antibodi
plasma
cell
express
receptor
ifnar
directli
confirm
contribut
protect
model
straightforward
sinc
mice
unabl
respond
interferon
highli
suscept
low
dose
vsv
infect
would
undoubtedli
kill
high
dose
rvsv
vaccin
virus
use
studi
nonetheless
observ
mice
immun
rvsv
ha
rapid
induct
neutral
antibodi
control
anim
mice
immun
either
rvsv
ha
vsv
rwt
significantli
less
morbid
weight
loss
temperatur
depress
control
mice
first
six
day
infect
consist
idea
innat
immun
respons
made
group
superior
mount
control
mice
earli
phase
infect
like
multipl
cytokin
induc
rvsv
immun
eg
contribut
protect
model
studi
defin
specif
cytokin
respons
induc
rvsv
vaccin
requir
vaccinemedi
protect
necessari
also
possibl
rvsv
vector
could
induc
specif
cellular
humor
respons
influenza
outcompet
influenza
viru
result
show
clear
tempor
separ
adapt
immun
respons
induc
influenza
infect
alon
vsv
mock
vaccin
control
mice
versu
induc
rvsv
ha
vaccin
presenc
absenc
influenza
challeng
mice
challeng
influenza
vaccin
rvsv
ha
develop
antiha
cell
two
three
day
earlier
peripher
blood
antiha
cell
respons
significantli
greater
magnitud
lung
control
mockvaccin
mice
vaccin
empti
vector
mice
receiv
rvsv
ha
alon
without
flu
also
detect
antiha
cell
peripher
blood
day
immun
result
demonstr
vaccin
rvsv
ha
result
rapid
induct
antiha
cell
presenc
influenza
affect
either
posit
neg
speed
cell
induc
respons
rvsv
ha
although
magnitud
respons
slightli
reduc
coinfect
mice
earli
stage
infect
versu
immun
rvsv
ha
absenc
flu
despit
vigor
induct
haspecif
cell
lung
peripheri
rvsv
ha
vaccin
mice
deplet
cell
anim
increas
morbid
delay
recoveri
reduc
surviv
demonstr
cell
essenti
protect
model
although
preclud
possibl
cell
especi
direct
conserv
antigen
might
contribut
protect
heterolog
challeng
virus
interestingli
induct
antiha
cell
mice
challeng
influenza
vaccin
rvsv
ha
markedli
synergist
two
week
challeng
onward
day
challeng
coinfect
mice
respons
significantli
higher
magnitud
mice
infect
either
viru
alon
synergist
effect
present
mice
challeng
flu
immun
rvsv
empti
vector
suggest
synergi
due
simpli
nonspecif
adjuv
effect
vsv
dissect
reason
observ
synergi
determin
effect
coinfect
rvsv
ha
flu
long
term
memori
cell
respons
import
area
investig
mice
challeng
influenza
vaccin
rvsv
ha
detect
serum
neutral
antibodi
influenza
two
day
earlier
day
vs
day
control
mice
neutral
antibodi
correl
protect
influenza
human
anim
assum
primari
mechan
exist
influenza
vaccin
mediat
protect
human
vaccine
predict
induct
neutral
antibodi
crucial
protect
vaccin
studi
b
cell
deplet
specif
timepoint
vaccinationchalleng
requir
confirm
hypothesi
data
exclud
possibl
vaccin
rvsv
ha
vsv
rwt
alter
overal
pulmonari
system
cytokin
milieu
challeng
vaccin
anim
elabor
inflammatori
cytokin
major
sourc
patholog
influenza
infect
possibl
presenc
vaccin
viru
reduc
alter
inflammatori
respons
benefici
manner
detail
analysi
pulmonari
system
cytokin
respons
rvsv
immun
context
preexist
flu
infect
import
futur
direct
result
consist
model
diagram
figur
rvsv
ha
vsv
rwt
rapidli
induc
nonspecif
antivir
respons
protect
vaccine
equal
approxim
day
challeng
predict
reason
mice
receiv
empti
vector
equal
protect
day
challeng
onward
make
antigen
specif
respons
influenza
data
suggest
neutral
antibodi
reduc
pulmonari
viral
load
mice
receiv
rvsv
ha
clearanc
influenza
viru
infect
cell
may
aid
absolut
depend
upon
action
haspecif
ctl
import
establish
futur
studi
maximum
length
time
rvsv
ha
vaccin
delay
retain
full
protect
studi
rvsv
vaccin
deliv
immedi
challeng
mock
immun
control
mice
die
day
challeng
rvsv
ha
vaccin
mice
detect
cell
respons
day
neutral
antibodi
respons
day
challeng
delay
rvsv
immun
delay
develop
immun
respons
proport
anticip
abl
delay
rvsv
ha
immun
day
challeng
retain
protect
summari
result
demonstr
vaccin
rvsv
ha
protect
mice
lethal
influenza
challeng
vaccin
viru
deliv
system
hour
challeng
experi
precis
defin
mechan
specif
nonspecif
contribut
vaccin
efficaci
necessari
optim
vaccin
design
understand
fine
differ
host
respons
viral
antigen
natur
context
versu
respons
viral
vector
vaccin
also
import
compar
head
head
studi
efficaci
exist
influenza
vaccin
use
therapeut
rvsv
ha
vaccin
use
therapeut
final
addit
rvsv
express
conserv
influenza
antigen
vaccin
may
broaden
efficaci
protect
highli
pathogen
avian
newli
emerg
influenza
strain
could
achiev
adult
femal
balbc
mice
challeng
intranas
immedi
within
minut
influenza
challeng
mice
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
vsv
rwt
immun
intramuscularli
pfu
rvsv
ha
mice
monitor
surviv
weight
loss
panel
b
chang
bodi
temperatur
panel
c
mice
human
euthan
bodi
weight
reach
preinfect
bodi
weight
two
consecut
day
rvsv
ha
immun
mice
significantli
higher
rate
surviv
mice
receiv
vsv
mantelcox
test
vaccin
empti
vector
vsv
rwt
mantelcox
test
experi
perform
total
four
time
consist
result
adult
femal
balbc
mice
challeng
intranas
immedi
within
minut
influenza
challeng
mice
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
vsv
rwt
immun
intramuscularli
pfu
rvsv
ha
five
addit
mice
mockchalleng
pb
alon
immun
intramuscularli
pfu
rvsv
ha
mice
monitor
surviv
panel
weight
loss
panel
b
induct
serum
panel
c
mice
human
euthan
bodi
weight
reach
preinfect
bodi
weight
two
consecut
day
mice
challeng
flu
immun
rvsv
ha
significantli
higher
rate
surviv
mice
receiv
vsv
mantelcox
test
vaccin
empti
vector
vsv
rwt
mantelcox
test
graph
panel
c
show
concentr
pg
ml
individu
assay
hr
timepoint
sera
vaccin
control
mice
per
group
measur
elisa
amount
induc
mice
immun
empti
vector
vsv
rwt
significantli
differ
amount
induc
mice
immun
specif
vector
rvsv
ha
adult
femal
balbc
mice
challeng
intranas
immedi
within
minut
influenza
challeng
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
immun
intramuscularli
pfu
rvsv
ha
timepoint
shown
four
mice
per
group
sacrif
amount
influenza
andor
rvsv
lung
determin
plaqu
assay
infecti
vsv
detect
lung
mice
time
graph
show
averag
pulmonari
viral
load
influenza
group
pfug
begin
eighth
day
challeng
indic
asterisk
graph
averag
pulmonari
viral
load
mice
vaccin
rvsv
ha
significantli
lower
averag
viral
load
control
mice
vaccin
empti
vector
vsv
rwt
p
via
oneway
anova
tukey
multipl
comparison
test
adult
femal
balbc
mice
challeng
intranas
immedi
within
minut
influenza
challeng
mice
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
vsvrwt
immun
intramuscularli
pfu
rvsv
ha
five
addit
mice
mockchalleng
pb
alon
immun
intramuscularli
pfu
rvsv
ha
panel
b
show
repres
fac
plot
tetram
stain
lymphocyt
isol
peripher
blood
panel
whole
lung
panel
b
challeng
rvsv
ha
vaccin
mice
isol
sixth
day
immun
challeng
panel
c
show
timecours
antiha
cell
respons
peripher
blood
panel
c
whole
lung
panel
vaccin
anim
nat
least
mice
per
group
per
day
analyz
individu
bar
graph
repres
averag
percent
cell
bind
mhc
class
tetram
specif
k
restrict
ha
epitop
immun
group
asterisk
bar
repres
day
mice
challeng
influenza
vaccin
rvsv
ha
significantli
antiha
specif
cell
mice
challeng
influenza
vaccin
empti
vector
challeng
influenza
sham
vaccin
diluent
alon
p
via
anova
tukey
multipl
comparison
test
panel
e
show
outcom
challeng
vaccin
mice
deplet
cell
open
squar
cell
deplet
mice
surviv
cours
weight
loss
significantli
differ
observ
cell
intact
mice
experi
deplet
perform
three
time
consist
result
adult
femal
balbc
mice
challeng
intranas
immedi
within
minut
influenza
challeng
mice
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
vsv
rwt
immun
intramuscularli
pfu
rvsv
ha
five
addit
mice
mockchalleng
pb
alon
immun
intramuscularli
pfu
rvsv
ha
graph
show
serum
neutral
titer
measur
microneutr
assay
use
pool
serum
sampl
least
vaccin
control
anim
timepoint
day
six
challeng
mice
vaccin
rvsv
ha
detect
titer
indic
arrow
graph
data
shown
singl
experi
perform
total
three
time
consist
result
adult
femal
balbc
mice
challeng
intranas
indic
time
influenza
challeng
mice
either
intramuscularli
shaminocul
diluent
alon
immun
intramuscularli
pfu
rvsv
empti
vector
vsv
rwt
immun
intramuscularli
pfu
rvsv
ha
mice
immun
rvsv
ha
hour
invert
triangl
hour
open
diamond
challeng
surviv
barefoot
model
show
rel
induct
adapt
immun
respons
rvsv
ha
versu
control
mice
immun
vsv
rwt
receiv
vsv
immun
orang
arrow
highlight
earlier
induct
serum
neutral
ab
rvsv
ha
immun
mice
